Home/Filings/4/0001790340-25-000022
4//SEC Filing

Bookman Michael 4

Accession 0001790340-25-000022

CIK 0001790340other

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 4:06 PM ET

Size

5.4 KB

Accession

0001790340-25-000022

Insider Transaction Report

Form 4
Period: 2025-02-05
Bookman Michael
CHIEF LEGAL OFFICER, SECRETARY
Transactions
  • Award

    Stock Option

    2025-02-05+110,000110,000 total
    Exercise: $1.91Exp: 2035-02-05Class A Common Stock (110,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2025, and will be fully vested and exercisable on January 1, 2029.

Issuer

Immuneering Corp

CIK 0001790340

Entity typeother

Related Parties

1
  • filerCIK 0001840339

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:06 PM ET
Size
5.4 KB